|
Market Closed -
Euronext Paris
00:55:00 07/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 8.840 EUR | -4.20% |
|
+2.31% | -47.54% |
| 10-20 | Sensorion Announces Appointment of Peter Weber as Chief Medical Officer, Effective November 2, 2026 | CI |
| 10-19 | Sensorion rallies after appointment of chief medical officer |  |
Company Valuation: Sensorion
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 153.4 | 29.56 | 80.38 | 191 | 101.3 | 91.1 | - |
| Change | - | -80.74% | 171.97% | 137.65% | -47% | -10.03% | - |
| Enterprise Value (EV) 1 | 107.4 | 7.116 | 80.38 | 126.4 | 55.03 | 17.1 | 16.1 |
| Change | - | -93.38% | 1,029.56% | 57.22% | -56.45% | -68.93% | -5.85% |
| P/E | -10.1x | -1.28x | -2.53x | -7.07x | -3.37x | -2.64x | -3.95x |
| PBR | - | - | - | - | - | - | - |
| PEG | - | -0x | 0.1x | 0.2x | -0.3x | 0.1x | 0.1x |
| Capitalization / Revenue | 35.3x | 5.9x | 14.1x | 28.7x | 17.4x | 19.5x | 5.72x |
| EV / Revenue | 24.7x | 1.42x | 14.1x | 19x | 9.47x | 3.67x | 1.01x |
| EV / EBITDA | -7.31x | -0.32x | -3.65x | -4.64x | -1.88x | -0.49x | -0.75x |
| EV / EBIT | -7.15x | -0.31x | -3.6x | -4.45x | -1.79x | -0.48x | -0.73x |
| EV / FCF | -9.56x | -0.31x | - | -5.74x | -2x | -0.63x | 10.9x |
| FCF Yield | -10.5% | -321% | - | -17.4% | -50% | -158% | 9.13% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -9.5 | -14.5 | -8.5 | -4.5 | -5 | -3.35 | -2.24 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 4.349 | 5.006 | 5.698 | 6.653 | 5.814 | 4.663 | 15.92 |
| EBITDA 1 | -14.69 | -22.37 | -22.04 | -27.24 | -29.31 | -34.95 | -21.55 |
| EBIT 1 | -15.02 | -23.14 | -22.31 | -28.4 | -30.75 | -35.4 | -21.93 |
| Net income 1 | -15.14 | -23.21 | -22.06 | -25.97 | -29.43 | -36 | -28.79 |
| Net Debt 1 | -46.02 | -22.44 | - | -64.66 | -46.22 | -74 | -75 |
| Reference price 2 | 96.300 | 18.500 | 21.500 | 31.800 | 16.850 | 8.840 | 8.840 |
| Nbr of stocks (in thousands) | 1,593 | 1,598 | 3,739 | 6,007 | 6,009 | 10,305 | - |
| Announcement Date | 28/4/22 | 16/3/23 | 29/2/24 | 14/3/25 | 17/3/26 | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.64x | 3.67x | -0.49x | - | 102M | |
| 17.43x | 6.6x | 12.65x | 1.71% | 65.94B | |
| 38.45x | 6.85x | 20.42x | 0.85% | 56.53B | |
| 30.07x | 8.27x | 26.77x | 0.06% | 56.88B | |
| 49.29x | 6.27x | 34.36x | -.--% | 46.49B | |
| 35.48x | 3.35x | 14.48x | -.--% | 44.8B | |
| -22.45x | 63.4x | -21.48x | -.--% | 41.59B | |
| 35.89x | 8.84x | 23.03x | 0.37% | 35.35B | |
| 37.6x | 8.06x | 26.12x | -.--% | 33.29B | |
| 28.81x | 6.09x | 15.79x | -.--% | 24.92B | |
| Average | 24.79x | 12.14x | 15.16x | 0.33% | 40.59B | |
| Weighted average by Cap. | 27.64x | 12.57x | 17.10x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALSEN Stock
- Valuation Sensorion
Select your edition
All financial news and data tailored to specific country editions
